Author/Authors :
Namjou، Z نويسنده Nursing Student, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran , , Ghilian، R نويسنده Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran , , Hashemi، A نويسنده Department of Pediatrics, Hematology, Oncology and Genetics Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, , , Vojdanifard ، F نويسنده Pediatric Nurse, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran , , Bakhshi، F نويسنده Nursing Student, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran , , Dehghani، Kh نويسنده Department of Pediatrics, Hematology, Oncology and Genetics Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yaz ,
Abstract :
Abstract
Background
Bone mineral density (BMD) may be occurred following treatment of Acute lymphoblastic Leukemia (ALL). 25-hydroxyvitamin D insufficiency has been described in these patients. In this Randomized Control Trial (RCT) we assessed the effectiveness of oral vitamin D administration after one year of treatment to protect bone density.
Materials and Methods
Twenty-four survivors of ALL (17 males and 7 females), who had completed their treatment with oral vitamin D supplement, at least 1 yr previously, and Twenty-five (20 males and 5 females) control group were examined with dual energy x-ray absorptiometry of the total body and L2–L4 vertebrae and neck of femur.
Result
Average of BMD (g/cm2) was significantly increased in oral vitamin D supplemented children (p=0.038) but average of Z-score decrease (p=0.006). Osteoporosis in this group was 4.2% and in control group, 40.9%.
Conclusion
Oral vitamin D supplementation to ALL children during 1 year did not show impact on Z-score and BMD (g/cm2). In the other hand osteoporosis decreased in this group.
